US Stock MarketDetailed Quotes

MDGL Madrigal Pharmaceuticals

Watchlist
  • 350.700
  • -4.150-1.17%
Close Nov 8 16:00 ET
  • 349.000
  • -1.700-0.48%
Post 20:01 ET
7.65BMarket Cap-14011P/E (TTM)

Madrigal Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Madrigal Pharmaceuticals Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
34.41M
62.18M
+27.76M
Beat Est.
--
--
+80.67%
EPS
-6.92
-4.92
+2.00
Beat Est.
-29.63%
+7.87%
+28.93%
Analyst Rating
Strong Buy

Nov 9, 2024

Madrigal Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 97.442M --
-- 2024/Q4 -- / 92.525M --
Oct 31, 2024 2024/Q3 62.175M / 34.414M --
Aug 7, 2024 2024/Q2 14.638M / 4.383M --
May 7, 2024 2024/Q1 0.000 / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 97.442M--
--2024/Q4-- / 92.525M--
Oct 31, 20242024/Q362.175M / 34.414M--
Aug 7, 20242024/Q214.638M / 4.383M--
May 7, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Madrigal Pharmaceuticals Earnings Reports

  • Madrigal Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 31 21:06

  • Madrigal Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 7 21:01

  • Madrigal Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 21:04

  • Madrigal Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 28 19:37

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 9, 2024

    Strong Buy

    • Buy

      90.91%

    • Hold

      0.00%

    • Sell

      9.09%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data